ANTG is pleased to announced it has become the first Australian member of the Global Cannabis Partnership (GCP), a not-for-profit collaboration of leaders in the government-sanctioned cannabis industry. The partnership offers a great opportunity for the company to take part in shaping the future of medicinal cannabis industry. Read the article here.
ANTG appoints new Business Operations Manager Australian Natural Therapeutics […]
ANTG’s Eve Cannabis product reveals its potential to kill or inhibit cancer cells without impacting normal cells…
ANTG has listed two new THC-dominant medicinal cannabis strains on the Australian Register of Therapeutic Goods (ARTG).
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.
LEARN ABOUT ANTG HERE >